Company Filing History:
Years Active: 2021
Title: Innovations of Anna L Blobaum
Introduction
Anna L Blobaum is a prominent inventor based in Brentwood, TN (US). She has made significant contributions to the field of neuroscience through her innovative research and development of novel compounds. With a total of 2 patents to her name, her work focuses on addressing neurological and psychiatric disorders.
Latest Patents
Anna's latest patents include "Isoquinoline ether compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction." This patent describes isoquinoline ether compounds that serve as allosteric potentiators of the metabotropic glutamate receptor subtype 4 (mGluR4). The patent outlines synthetic methods for creating these compounds, pharmaceutical compositions that include them, and their applications in treating disorders associated with glutamate dysfunction. Another significant patent is for "Positive allosteric modulators of the muscarinic acetylcholine receptor M1." This patent details positive allosteric modulators of the muscarinic acetylcholine receptor M, along with pharmaceutical compositions and methods for treating neurological and psychiatric disorders.
Career Highlights
Anna L Blobaum is affiliated with Vanderbilt University, where she conducts her research. Her work has been instrumental in advancing the understanding of neurological dysfunction and developing potential therapeutic solutions.
Collaborations
Some of her notable collaborators include P Jeffrey Conn and Craig William Lindsley. Their combined expertise has contributed to the success of her research initiatives.
Conclusion
Anna L Blobaum's innovative work in the field of neuroscience highlights her commitment to improving treatments for neurological and psychiatric disorders. Her patents reflect her significant contributions to medical science and her dedication to advancing healthcare solutions.